|
US4394448A
(en)
|
1978-02-24 |
1983-07-19 |
Szoka Jr Francis C |
Method of inserting DNA into living cells
|
|
US4529561A
(en)
|
1978-03-24 |
1985-07-16 |
The Regents Of The University Of California |
Method for producing liposomes in selected size range
|
|
US4241046A
(en)
|
1978-11-30 |
1980-12-23 |
Papahadjopoulos Demetrios P |
Method of encapsulating biologically active materials in lipid vesicles
|
|
US4925661A
(en)
|
1984-04-19 |
1990-05-15 |
Leaf Huang |
Target-specific cytotoxic liposomes
|
|
US4957735A
(en)
|
1984-06-12 |
1990-09-18 |
The University Of Tennessee Research Corporation |
Target-sensitive immunoliposomes- preparation and characterization
|
|
US4755388A
(en)
|
1984-11-09 |
1988-07-05 |
The Regents Of The University Of California |
Liposome-encapsulated 5-fluoropyrimidines and methods for their use
|
|
DE3542773A1
(de)
|
1985-12-04 |
1987-06-11 |
Roehm Pharma Gmbh |
Hautwirksame pharmaka mit liposomen als wirkstofftraeger
|
|
US4828837A
(en)
|
1987-03-30 |
1989-05-09 |
Liposome Technology, Inc. |
Non-crystalline minoxidil composition, its production and application
|
|
US5077211A
(en)
|
1988-07-06 |
1991-12-31 |
Applied Genetics, Inc. |
Purification and administration of dna repair enzymes
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
US5043164A
(en)
|
1989-01-17 |
1991-08-27 |
The University Of Tennessee Research Corporation |
Blood-stable, cholesterol-free liposomes
|
|
US5064655A
(en)
|
1989-02-24 |
1991-11-12 |
Liposome Technology, Inc. |
Liposome gel composition and method
|
|
US5744101A
(en)
|
1989-06-07 |
1998-04-28 |
Affymax Technologies N.V. |
Photolabile nucleoside protecting groups
|
|
US5264618A
(en)
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
|
US5270339A
(en)
|
1991-04-05 |
1993-12-14 |
Kanagafuchi Kagaku Kogyo Kabushiki Kaisha |
Phenoxybenzene derivative
|
|
US5491069A
(en)
|
1994-02-18 |
1996-02-13 |
The Regents Of The University Of California |
Biomarkers of cell senescence
|
|
US5888764A
(en)
|
1995-01-20 |
1999-03-30 |
Uab Research Foundation |
Human fas gene promoter region
|
|
DE19713393C2
(de)
|
1997-04-01 |
2002-12-05 |
Apotech Res & Dev Ltd |
Flip-Gen und Flip-Protein
|
|
JPH11349568A
(ja)
|
1998-06-08 |
1999-12-21 |
Maruho Co Ltd |
ラクタム誘導体及びその医薬用途
|
|
CA2338328A1
(en)
*
|
1998-07-21 |
2000-02-03 |
Thomas Jefferson University |
Small molecule inhibitors of bcl-2 proteins
|
|
AUPR038200A0
(en)
|
2000-09-26 |
2000-10-19 |
Beta Peptide Foundation Pty Ltd, The |
Compositions and methods for delaying, preventing, rejuvenating or reversing senescence
|
|
WO2002097053A2
(en)
|
2001-05-30 |
2002-12-05 |
The Regents Of The University Of Michigan |
Small molecule antagonists of bcl2 family proteins
|
|
ES2276895T3
(es)
|
2002-05-07 |
2007-07-01 |
Institut Pasteur |
Cribado de peptidos qque inhiben la union de pp1c a las proteinas bcl-2, bcl-xi y bcl-w.
|
|
AU2003245436A1
(en)
|
2003-01-23 |
2004-08-23 |
The Trustees Of Columbia University In The City Of New York |
Old-35, a gene associated with senescence and terminal cell differentiation, and uses thereof
|
|
ES2382377T3
(es)
|
2003-05-30 |
2012-06-07 |
Gemin X Pharmaceuticals Canada Inc. |
Compuestos triheterocíclicos, composiciones, y métodos para tratar cáncer
|
|
US20050208151A1
(en)
|
2003-10-30 |
2005-09-22 |
Entelos, Inc. |
Treatment of rheumatoid arthritis with FLIP antagonists
|
|
US7973161B2
(en)
|
2003-11-13 |
2011-07-05 |
Abbott Laboratories |
Apoptosis promoters
|
|
JP2007525661A
(ja)
|
2003-12-12 |
2007-09-06 |
セントルイス ユニバーシティー |
大分子その他の分析物の検出用生物センサー
|
|
RU2361872C2
(ru)
|
2004-05-26 |
2009-07-20 |
Эйсай Ар Энд Ди Менеджмент Ко., Лтд. |
Циннамидное соединение
|
|
AU2005277223C1
(en)
|
2004-08-20 |
2009-05-21 |
The Regents Of The University Of Michigan |
Small molecule inhibitors of anti-apoptotic Bcl-2 family members and the uses thereof
|
|
US7533068B2
(en)
|
2004-12-23 |
2009-05-12 |
D-Wave Systems, Inc. |
Analog processor comprising quantum devices
|
|
PL1888550T3
(pl)
|
2005-05-12 |
2014-12-31 |
Abbvie Bahamas Ltd |
Promotory apoptozy
|
|
EP2135078B1
(en)
|
2007-03-09 |
2013-08-21 |
DiscoveRx Corporation |
Methods for identifying agents and their use for the prevention or stabilization of fibrosis
|
|
EA200901212A1
(ru)
|
2007-03-29 |
2010-04-30 |
Новартис Аг |
3-имидазолилиндолы, предназначенные для лечения пролиферативных заболеваний
|
|
US20100310504A1
(en)
|
2007-09-26 |
2010-12-09 |
Lowe Scott W |
Methods for treating fibrosis by modulating cellular senescence
|
|
US8039668B2
(en)
|
2008-10-17 |
2011-10-18 |
Burnham Institute For Medical Research |
Naphthalene-based inhibitors of anti-apoptotic proteins
|
|
WO2009085216A2
(en)
|
2007-12-20 |
2009-07-09 |
Squicor |
Compositions and methods for detecting or elimninating senescent cells to diagnose or treat disease
|
|
US20090312373A1
(en)
|
2008-03-11 |
2009-12-17 |
The General Hospital Corporation |
Methods for the treatment of cancer using piperlongumine and piperlongumine analogs
|
|
US8168784B2
(en)
|
2008-06-20 |
2012-05-01 |
Abbott Laboratories |
Processes to make apoptosis promoters
|
|
US20100086941A1
(en)
|
2008-10-01 |
2010-04-08 |
Adami Guy R |
Methods for determining aged based accumulation of senescent cells using senescence specific DNA damage markers
|
|
NZ593536A
(en)
|
2008-12-19 |
2013-07-26 |
Genentech Inc |
Quinoline derivatives and methods of use
|
|
WO2010080503A1
(en)
|
2008-12-19 |
2010-07-15 |
Genentech, Inc. |
Heterocyclic compounds and methods of use
|
|
WO2010138588A2
(en)
|
2009-05-26 |
2010-12-02 |
Abbott Laboratories |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
|
EP2289528A1
(en)
|
2009-07-21 |
2011-03-02 |
DSM IP Assets B.V. |
Novel nutraceutical compositions containing black pepper or its constituents improving mental performance
|
|
US8318737B2
(en)
|
2009-09-02 |
2012-11-27 |
Canthera Therapeutics Inc. |
Compounds and compositions for treating cancer
|
|
US8349832B2
(en)
|
2009-09-02 |
2013-01-08 |
Canthera Therapeutics |
Compounds and compositions for treating cancer
|
|
US20120157455A1
(en)
|
2009-09-02 |
2012-06-21 |
Canthera Therapeutics, Inc. |
Compounds And Compositions For Treating Cancer
|
|
EP2519260A2
(en)
|
2009-12-31 |
2012-11-07 |
Deutsches Krebsforschungszentrum |
Novel modulators of trail signalling
|
|
CN101774875A
(zh)
|
2010-01-08 |
2010-07-14 |
北京欧凯纳斯科技有限公司 |
一种荜拔酰胺类化合物的合成方法
|
|
CN102125552A
(zh)
|
2010-01-20 |
2011-07-20 |
李绍路 |
荜茇酰胺衍生物在制备治疗癌症的药物中的用途及其药物组合物
|
|
CN102146054A
(zh)
|
2010-02-10 |
2011-08-10 |
新昌县来益科技开发有限公司 |
荜茇酰胺衍生物及其药物组合物和在制备抑制肿瘤生长的药物中的用途
|
|
WO2011130395A1
(en)
|
2010-04-13 |
2011-10-20 |
University Of Utah Research Foundation |
Inhibitors of flip to treat cancer
|
|
ES2603129T3
(es)
|
2010-11-23 |
2017-02-23 |
Abbvie Ireland Unlimited Company |
Métodos de tratamiento utilizando inhibidores selectivos de Bcl-2
|
|
EP2668180B1
(en)
|
2011-01-25 |
2018-08-01 |
The Regents of The University of Michigan |
Bcl-2/bcl-xl inhibitors for use in the treatment of cancer
|
|
US8940737B2
(en)
|
2011-10-14 |
2015-01-27 |
Abbvie Inc. |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
|
EP2602330A1
(en)
|
2011-12-07 |
2013-06-12 |
Palacky University, Olomouc |
Method of determination of cancer cell drug sensitivity towards Aurora kinase inhibitors and overcoming their resistance
|
|
KR102668696B1
(ko)
|
2012-01-12 |
2024-05-29 |
예일 유니버시티 |
E3 유비퀴틴 리가아제에 의한 표적 단백질 및 다른 폴리펩티드의 증진된 분해를 위한 화합물 및 방법
|
|
US9828344B2
(en)
|
2012-06-01 |
2017-11-28 |
LEIBNIZ-INSTITUT FÜR ALTERSFORSCHUNG FRITZ-LIPMANN-INSTITUT e.V. (FLI) |
Inhibitors of the notch signaling pathway and secretion for use in medicine
|
|
US9108923B2
(en)
|
2012-07-20 |
2015-08-18 |
Howard Hughes Medical Institute |
Compounds, compositions, and methods for cancer therapy
|
|
CN103601670B
(zh)
|
2012-11-20 |
2016-06-15 |
中国人民解放军第二军医大学 |
荜拔酰胺类似物及其制备方法与应用
|
|
WO2014089124A1
(en)
|
2012-12-03 |
2014-06-12 |
Cenexys, Inc. |
Immunogenic compositions for inducing an immune response for elimination of senescent cells
|
|
GB201311910D0
(en)
|
2013-07-03 |
2013-08-14 |
Glaxosmithkline Ip Dev Ltd |
Novel Compounds
|
|
EP3689886A1
(en)
|
2013-01-16 |
2020-08-05 |
The Regents of The University of Michigan |
Bcl-2/bcl-xl inhibitors and their use in the treatment of cancer
|
|
RU2015149680A
(ru)
|
2013-04-21 |
2017-05-24 |
Йеда Ресеарч Энд Девелопмент Ко. Лтд. |
Агенты для подавления активности и/или снижения количества bcl-xl и/или bcl-w
|
|
IL286427B2
(en)
|
2014-01-28 |
2024-08-01 |
Mayo Found Medical Education & Res |
Inhibitors bcl-2 anti-apoptotic protein family members for treatment of non cancer pulmonary disease or an opthalmic disease
|
|
US10002107B2
(en)
|
2014-03-12 |
2018-06-19 |
D-Wave Systems Inc. |
Systems and methods for removing unwanted interactions in quantum devices
|
|
RU2738833C9
(ru)
|
2014-04-14 |
2022-02-28 |
Арвинас, Оперэйшнз, Инк. |
Имидные модуляторы протеолиза и способы их применения
|
|
EP3139942B1
(en)
|
2014-05-05 |
2019-12-18 |
Bioventures, Llc |
COMPOSITIONS AND METHODS FOR INHIBITING ANTIAPOPTOTIC Bcl-2 PROTEINS AS ANTI-AGING AGENTS
|
|
WO2016014625A1
(en)
|
2014-07-22 |
2016-01-28 |
Board Of Trustees Of The University Of Arkansas |
Compositions and methods for selectively depleting senescent cells
|
|
US10071164B2
(en)
|
2014-08-11 |
2018-09-11 |
Yale University |
Estrogen-related receptor alpha based protac compounds and associated methods of use
|
|
US10552755B2
(en)
|
2014-08-22 |
2020-02-04 |
D-Wave Systems Inc. |
Systems and methods for improving the performance of a quantum processor to reduce intrinsic/control errors
|
|
US9694084B2
(en)
|
2014-12-23 |
2017-07-04 |
Dana-Farber Cancer Institute, Inc. |
Methods to induce targeted protein degradation through bifunctional molecules
|
|
WO2016118859A1
(en)
|
2015-01-22 |
2016-07-28 |
Board Of Trustees Of The University Of Arkansas |
Compositions and methods for selectively depleting senescent cells comprising flip
|
|
WO2016118855A1
(en)
|
2015-01-22 |
2016-07-28 |
Board Of Trustees Of The University Of Arkansas |
Compositions and methods for selectively depleting senescent cells comprising death receptors
|
|
US20180000816A1
(en)
|
2015-02-06 |
2018-01-04 |
Unity Biotechnology, Inc. |
Use of a Heterocyclic Bcl-xL Inhibitor and Related Analogs for Removing Senescent Cells in the Treatment of Eye Diseases and Other Age-Related Conditions
|
|
WO2016182608A2
(en)
|
2015-02-10 |
2016-11-17 |
D-Wave Systems Inc. |
Systems, devices, articles, and methods for quantum processor architecture
|
|
CA2979895A1
(en)
*
|
2015-03-18 |
2016-09-22 |
Immunobiochem Corporation |
Conjugates for the treatment of cancer targeted at intracellular tumor-associated antigens
|
|
EP3270917A4
(en)
|
2015-03-18 |
2018-08-08 |
Arvinas, Inc. |
Compounds and methods for the enhanced degradation of targeted proteins
|
|
CN105085620B
(zh)
|
2015-06-25 |
2018-05-08 |
中山大学附属第一医院 |
一种靶向泛素化降解Smad3的化合物
|
|
AU2016295984B2
(en)
|
2015-07-21 |
2021-05-27 |
Fundació Investigació Hospital General Universitari De València Per A La Investigació Biomèdica I Ciències De La Salut |
Combination comprising pterostilbene for the treatment of cancer
|
|
US10772962B2
(en)
|
2015-08-19 |
2020-09-15 |
Arvinas Operations, Inc. |
Compounds and methods for the targeted degradation of bromodomain-containing proteins
|
|
WO2017101851A1
(en)
|
2015-12-18 |
2017-06-22 |
Unity Biotechnology, Inc. |
Acylsulfonamide derivatives for treating senescence-associated diseases and disorders
|
|
US20190054097A1
(en)
|
2016-04-21 |
2019-02-21 |
Bioventures, Llc |
Compositions targeting senescent cells and the uses thereof
|
|
CN109152933B
(zh)
|
2016-04-21 |
2022-12-02 |
生物风险投资有限责任公司 |
诱导抗细胞凋亡bcl-2家族蛋白的降解的化合物及其用途
|
|
US10296352B2
(en)
|
2016-06-15 |
2019-05-21 |
University Of Southern California |
Nested quantum annealing correction
|
|
ES3041854T3
(en)
|
2018-01-22 |
2025-11-17 |
Bioventures Llc |
Bcl-2 proteins degraders for cancer treatment
|